EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Progress in targeting the NLRP3 signaling pathway for inflammatory bowel disease (Review)

Yubo Gong, Zhenqi Han, Siyi Wang, Xuefeng Li, Xinhua Chen, Bo Yang

Molecular Medicine Reports · 03.07.2025 · 32 (3) · 1-15

DOI: 10.3892/mmr.2025.13606 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Medicine Reports, online erschienen am 03.07.2025. Verfasst von Yubo Gong und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Acupuncture Massage, Changchun University of Traditional Chinese Medicine, Changchun, Jilin 130117, P.R. China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Inflammatory Bowel Diseases, Signal Transduction, Inflammasomes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory caspases pro‑inflammatory cytokines, such as IL‑1β IL‑18, constitute a critical part in the modulation of innate immune responses by the nucleotide‑binding domain leucine‑rich repeat protein (NLRP)3 inflammasome. The NLRP3 inflammasome, a cytosolic complex, is composed of three distinct classes of proteins‑sensor complexes, adaptor proteins, cysteine proteases. It is well‑established that this pathway can powerfully influence the pathophysiology of autoimmune diseases along with an association of a plethora of inflammatory conditions. Therefore, it is of great significance to elucidate the mechanisms through which NLRP3 participates in disease development functions as a potential target for pharmacological intervention. The present review discussed the function role of the NLRP3 inflammasome in inflammatory bowel disease and described the structure assembly and activation mechanism of the NLRP3 inflammasome. Additionally, it explored novel clinical viewpoints and therapeutic advances in targeted NLRP3 inflammasome therapy. In conclusion, the present review offered a comprehensive overview of inflammatory bowel disease and the NLRP3 inflammasome. It is expected to serve as a guide for future research, potentially leading to improved patient outcomes. The present review has been submitted as a pre‑print (https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4962722).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinInflammatory Bowel DiseasesSignal TransductionInflammasomesHumansAnimalsMolecular Targeted Therapy

Stichwörter der Autor:innen

cancerimmunityinflammasomeinflammasome inhibitorinflammatory bowel diseaseintestinal fibrosisintestinal floranucleotide‑binding domain leucine‑rich repeat protein 3

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesNLRP3 protein, human

Autor:innen und Institutionen

  • College of Acupuncture Massage, Changchun University of Traditional Chinese Medicine, Changchun, Jilin 130117, P.R. China.
  • Endoscopy Department, The Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, Jilin 130021, P.R. China.

Zitieren

APA

Gong, Y., Han, Z., Wang, S., Li, X., Chen, X., & Yang, B. (2025). Progress in targeting the NLRP3 signaling pathway for inflammatory bowel disease (Review). Molecular Medicine Reports, 32(3), 1-15. https://doi.org/10.3892/mmr.2025.13606

Vancouver

Gong Y, Han Z, Wang S, Li X, Chen X, Yang B. Progress in targeting the NLRP3 signaling pathway for inflammatory bowel disease (Review). Molecular Medicine Reports. 2025;32(3):1-15. doi:10.3892/mmr.2025.13606

BibTeX
@article{Gong2025,
  author = {Gong, Yubo and Han, Zhenqi and Wang, Siyi and Li, Xuefeng and Chen, Xinhua and Yang, Bo},
  title = {Progress in targeting the NLRP3 signaling pathway for inflammatory bowel disease (Review)},
  journal = {Molecular Medicine Reports},
  year = {2025},
  volume = {32},
  number = {3},
  pages = {1--15},
  doi = {10.3892/mmr.2025.13606}
}
Kostenlos starten →